HRTX vs. NVDA
HRTX (Heron Therapeutics, Inc.) and NVDA (NVIDIA Corporation) are both stocks. HRTX operates in Biotechnology (Healthcare), while NVDA operates in Semiconductors (Technology). Over the past 10 years, HRTX returned -31.62%/yr vs 68.84%/yr for NVDA. At a 0.15 correlation, their price movements are largely independent.
Performance
HRTX vs. NVDA - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, HRTX achieves a -65.63% return, which is significantly lower than NVDA's 15.15% return. Over the past 10 years, HRTX has underperformed NVDA with an annualized return of -31.62%, while NVDA has yielded a comparatively higher 68.84% annualized return.
HRTX
- 1D
- -0.71%
- 1M
- -63.38%
- YTD
- -65.63%
- 6M
- -64.82%
- 1Y
- -77.66%
- 3Y*
- -26.39%
- 5Y*
- -49.46%
- 10Y*
- -31.62%
NVDA
- 1D
- -3.62%
- 1M
- 8.20%
- YTD
- 15.15%
- 6M
- 19.59%
- 1Y
- 52.10%
- 3Y*
- 76.15%
- 5Y*
- 65.05%
- 10Y*
- 68.84%
HRTX vs. NVDA - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
HRTX Heron Therapeutics, Inc. | -65.63% | -15.03% | -10.00% | -32.00% | -72.62% | -56.86% | -9.94% | -9.41% | 43.31% | 38.17% |
NVDA NVIDIA Corporation | 15.15% | 38.92% | 171.25% | 239.02% | -50.26% | 125.48% | 122.30% | 76.94% | -30.82% | 81.99% |
Correlation
The correlation between HRTX and NVDA is 0.23, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.23 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.20 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.28 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.26 |
Correlation (All Time) Calculated using the full available price history since Jan 25, 1999 | 0.15 |
The correlation between HRTX and NVDA shifts across timeframes, from 0.15 (all time) to 0.28 (5 years), reflecting how their relationship changes across market environments.
Fundamentals
HRTX:
$84.73M
NVDA:
$5.24T
HRTX:
-$0.18
NVDA:
$6.53
HRTX:
0.50
NVDA:
20.72
HRTX:
10.48
NVDA:
26.80
HRTX:
$150.71M
NVDA:
$253.49B
HRTX:
$107.18M
NVDA:
$187.95B
HRTX:
-$20.56M
NVDA:
$192.76B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
HRTX vs. NVDA — Risk / Return Rank
HRTX
NVDA
HRTX vs. NVDA - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Heron Therapeutics, Inc. (HRTX) and NVIDIA Corporation (NVDA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| HRTX | NVDA | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | -0.97 | 1.53 | -2.50 |
Sortino ratioReturn per unit of downside risk | -1.63 | 2.15 | -3.78 |
Omega ratioGain probability vs. loss probability | 0.74 | 1.26 | -0.51 |
Calmar ratioReturn relative to maximum drawdown | -0.97 | 2.59 | -3.56 |
Martin ratioReturn relative to average drawdown | -1.76 | 6.36 | -8.12 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| HRTX | NVDA | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | -0.97 | 1.53 | -2.50 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.55 | 1.27 | -1.81 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | -0.42 | 1.39 | -1.80 |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.21 | 0.63 | -0.84 |
Drawdowns
HRTX vs. NVDA - Drawdown Comparison
The maximum HRTX drawdown since its inception was -99.96%, which is greater than NVDA's maximum drawdown of -89.72%. Use the drawdown chart below to compare losses from any high point for HRTX and NVDA.
Loading charts...
Drawdown Indicators
| HRTX | NVDA | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.96% | -89.72% | -10.24% |
Max Drawdown (1Y)Largest decline over 1 year | -79.96% | -20.21% | -59.75% |
Max Drawdown (3Y)Largest decline over 3 years | -88.42% | -36.88% | -51.54% |
Max Drawdown (5Y)Largest decline over 5 years | -97.31% | -66.34% | -30.97% |
Max Drawdown (10Y)Largest decline over 10 years | -98.94% | -66.34% | -32.60% |
Current DrawdownCurrent decline from peak | -99.96% | -8.90% | -91.06% |
Average DrawdownAverage peak-to-trough decline | -81.66% | -36.21% | -45.45% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 44.18% | 8.21% | +35.97% |
Volatility
HRTX vs. NVDA - Volatility Comparison
Heron Therapeutics, Inc. (HRTX) has a higher volatility of 64.87% compared to NVIDIA Corporation (NVDA) at 12.53%. This indicates that HRTX's price experiences larger fluctuations and is considered to be riskier than NVDA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| HRTX | NVDA | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 64.87% | 12.53% | +52.34% |
Volatility (6M)Calculated over the trailing 6-month period | 79.46% | 25.54% | +53.92% |
Volatility (1Y)Calculated over the trailing 1-year period | 80.29% | 34.22% | +46.07% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 90.98% | 51.69% | +39.29% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 76.16% | 49.80% | +26.36% |
Dividends
HRTX vs. NVDA - Dividend Comparison
HRTX has not paid dividends to shareholders, while NVDA's dividend yield for the trailing twelve months is around 0.02%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
HRTX Heron Therapeutics, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
NVDA NVIDIA Corporation | 0.02% | 0.02% | 0.03% | 0.03% | 0.11% | 0.05% | 0.12% | 0.27% | 0.46% | 0.29% | 0.45% | 1.20% |
Financials
HRTX vs. NVDA - Financials Comparison
This section allows you to compare key financial metrics between Heron Therapeutics, Inc. and NVIDIA Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
HRTX vs. NVDA - Profitability Comparison
HRTX - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Heron Therapeutics, Inc. reported a gross profit of 24.07M and revenue of 34.71M. Therefore, the gross margin over that period was 69.4%.
NVDA - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, NVIDIA Corporation reported a gross profit of 61.16B and revenue of 81.62B. Therefore, the gross margin over that period was 74.9%.
HRTX - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Heron Therapeutics, Inc. reported an operating income of -4.77M and revenue of 34.71M, resulting in an operating margin of -13.7%.
NVDA - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, NVIDIA Corporation reported an operating income of 53.54B and revenue of 81.62B, resulting in an operating margin of 65.6%.
HRTX - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Heron Therapeutics, Inc. reported a net income of -8.11M and revenue of 34.71M, resulting in a net margin of -23.4%.
NVDA - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, NVIDIA Corporation reported a net income of 58.32B and revenue of 81.62B, resulting in a net margin of 71.5%.
Frequently Asked Questions
HRTX and NVDA have a correlation of 0.23, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
HRTX has higher volatility (64.87%) compared to NVDA (12.53%). In terms of maximum drawdown, HRTX dropped -99.96% vs NVDA's -89.72%.
NVDA currently has the higher Sharpe Ratio (1.53 vs -0.97), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for HRTX and NVDA
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer